

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.52781906 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 5.36738035 |
| 3 | glutamate secretion (GO:0014047) | 5.16401954 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.14154244 |
| 5 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.04095363 |
| 6 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.73742924 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.62995137 |
| 8 | locomotory exploration behavior (GO:0035641) | 4.58746377 |
| 9 | regulation of synaptic vesicle transport (GO:1902803) | 4.48997324 |
| 10 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.40354009 |
| 11 | neuronal action potential propagation (GO:0019227) | 4.33172534 |
| 12 | vocalization behavior (GO:0071625) | 4.28843477 |
| 13 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.17073280 |
| 14 | neurotransmitter secretion (GO:0007269) | 4.13110803 |
| 15 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.95533223 |
| 16 | protein localization to synapse (GO:0035418) | 3.81611546 |
| 17 | neuromuscular process controlling posture (GO:0050884) | 3.81375982 |
| 18 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.74245295 |
| 19 | neuron cell-cell adhesion (GO:0007158) | 3.74041851 |
| 20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.69588318 |
| 21 | negative regulation of cell killing (GO:0031342) | 3.69588318 |
| 22 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.66320940 |
| 23 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.58972828 |
| 24 | cellular potassium ion homeostasis (GO:0030007) | 3.57953781 |
| 25 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.54907421 |
| 26 | regulation of ARF protein signal transduction (GO:0032012) | 3.53896405 |
| 27 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.51169536 |
| 28 | neurotransmitter transport (GO:0006836) | 3.46316177 |
| 29 | gamma-aminobutyric acid transport (GO:0015812) | 3.45800454 |
| 30 | exploration behavior (GO:0035640) | 3.43953665 |
| 31 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.43404233 |
| 32 | synaptic transmission, glutamatergic (GO:0035249) | 3.39029694 |
| 33 | neuron-neuron synaptic transmission (GO:0007270) | 3.33794023 |
| 34 | sodium ion export (GO:0071436) | 3.33574149 |
| 35 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.32188660 |
| 36 | long-term synaptic potentiation (GO:0060291) | 3.30462495 |
| 37 | regulation of synapse structural plasticity (GO:0051823) | 3.29008932 |
| 38 | glycine transport (GO:0015816) | 3.28164697 |
| 39 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.27622922 |
| 40 | transferrin transport (GO:0033572) | 3.25452737 |
| 41 | regulation of neurotransmitter levels (GO:0001505) | 3.22468261 |
| 42 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.22082358 |
| 43 | positive regulation of membrane potential (GO:0045838) | 3.20924749 |
| 44 | regulation of neurotransmitter secretion (GO:0046928) | 3.20281502 |
| 45 | adenosine receptor signaling pathway (GO:0001973) | 3.20205169 |
| 46 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.18774987 |
| 47 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.18774987 |
| 48 | acidic amino acid transport (GO:0015800) | 3.18429243 |
| 49 | signal complex assembly (GO:0007172) | 3.17130713 |
| 50 | L-glutamate transport (GO:0015813) | 3.14360768 |
| 51 | glutamate receptor signaling pathway (GO:0007215) | 3.14286373 |
| 52 | regulation of synaptic plasticity (GO:0048167) | 3.13847843 |
| 53 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.13149031 |
| 54 | neutrophil activation involved in immune response (GO:0002283) | 3.12237839 |
| 55 | amino acid import (GO:0043090) | 3.10996556 |
| 56 | activation of protein kinase A activity (GO:0034199) | 3.08771584 |
| 57 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.07783921 |
| 58 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.07297435 |
| 59 | cerebellar granule cell differentiation (GO:0021707) | 3.05133293 |
| 60 | long-term memory (GO:0007616) | 3.03416927 |
| 61 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.03334090 |
| 62 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.02935591 |
| 63 | ferric iron transport (GO:0015682) | 3.02708989 |
| 64 | trivalent inorganic cation transport (GO:0072512) | 3.02708989 |
| 65 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.99640694 |
| 66 | regulation of neurotransmitter transport (GO:0051588) | 2.98982174 |
| 67 | regulation of vesicle fusion (GO:0031338) | 2.98353458 |
| 68 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.97666748 |
| 69 | synaptic vesicle endocytosis (GO:0048488) | 2.96914138 |
| 70 | positive regulation of synapse maturation (GO:0090129) | 2.96667301 |
| 71 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.96591627 |
| 72 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.96587357 |
| 73 | proline transport (GO:0015824) | 2.95918021 |
| 74 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.94173675 |
| 75 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.90422075 |
| 76 | regulation of postsynaptic membrane potential (GO:0060078) | 2.89687522 |
| 77 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.88360991 |
| 78 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.87890071 |
| 79 | positive regulation of neurotransmitter transport (GO:0051590) | 2.85128584 |
| 80 | neuromuscular process controlling balance (GO:0050885) | 2.83912271 |
| 81 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.81754721 |
| 82 | adult walking behavior (GO:0007628) | 2.80664757 |
| 83 | positive regulation of synaptic transmission (GO:0050806) | 2.79303418 |
| 84 | regulation of glutamate secretion (GO:0014048) | 2.77766245 |
| 85 | membrane depolarization during action potential (GO:0086010) | 2.77737753 |
| 86 | transmission of nerve impulse (GO:0019226) | 2.76691975 |
| 87 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.75441490 |
| 88 | regulation of synaptic transmission (GO:0050804) | 2.74938762 |
| 89 | layer formation in cerebral cortex (GO:0021819) | 2.74363496 |
| 90 | cell communication by electrical coupling (GO:0010644) | 2.73592365 |
| 91 | membrane hyperpolarization (GO:0060081) | 2.73255638 |
| 92 | positive regulation of Rap GTPase activity (GO:0032854) | 2.72822539 |
| 93 | negative regulation of microtubule polymerization (GO:0031115) | 2.71136556 |
| 94 | postsynaptic membrane organization (GO:0001941) | 2.70972473 |
| 95 | synaptic transmission (GO:0007268) | 2.70561817 |
| 96 | establishment of synaptic vesicle localization (GO:0097480) | 2.70452790 |
| 97 | synaptic vesicle transport (GO:0048489) | 2.70452790 |
| 98 | L-amino acid import (GO:0043092) | 2.70154934 |
| 99 | regulation of regulated secretory pathway (GO:1903305) | 2.69425628 |
| 100 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.69066034 |
| 101 | potassium ion import (GO:0010107) | 2.66410655 |
| 102 | calcium ion-dependent exocytosis (GO:0017156) | 2.65572497 |
| 103 | membrane depolarization (GO:0051899) | 2.65283089 |
| 104 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.65244690 |
| 105 | response to auditory stimulus (GO:0010996) | 2.64454384 |
| 106 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.63260510 |
| 107 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.62489086 |
| 108 | presynaptic membrane organization (GO:0097090) | 2.61985298 |
| 109 | protein localization to endosome (GO:0036010) | 2.61440567 |
| 110 | neurotransmitter uptake (GO:0001504) | 2.60755750 |
| 111 | dicarboxylic acid transport (GO:0006835) | 2.59299042 |
| 112 | neuromuscular process (GO:0050905) | 2.59100588 |
| 113 | vesicle transport along microtubule (GO:0047496) | 2.58508193 |
| 114 | potassium ion homeostasis (GO:0055075) | 2.57932987 |
| 115 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.56560760 |
| 116 | negative regulation of amino acid transport (GO:0051956) | 2.56556389 |
| 117 | regulation of early endosome to late endosome transport (GO:2000641) | 2.56106120 |
| 118 | macrophage activation involved in immune response (GO:0002281) | 2.54051226 |
| 119 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.52980564 |
| 120 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.51679131 |
| 121 | regulation of mast cell degranulation (GO:0043304) | 2.50823492 |
| 122 | regulation of leukocyte degranulation (GO:0043300) | 2.50171970 |
| 123 | neuronal ion channel clustering (GO:0045161) | 2.47184902 |
| 124 | positive regulation of protein dephosphorylation (GO:0035307) | 2.45991852 |
| 125 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.42992984 |
| 126 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.42992984 |
| 127 | modulation by symbiont of host immune response (GO:0052553) | 2.42992984 |
| 128 | positive regulation by symbiont of host defense response (GO:0052509) | 2.42992984 |
| 129 | modulation by symbiont of host defense response (GO:0052031) | 2.42992984 |
| 130 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.42992984 |
| 131 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.42399754 |
| 132 | actin filament polymerization (GO:0030041) | 2.41278954 |
| 133 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.39725547 |
| 134 | regulation of platelet aggregation (GO:0090330) | 2.39497294 |
| 135 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.37512096 |
| 136 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.32753140 |
| 137 | regulation of Rap GTPase activity (GO:0032317) | 2.29845049 |
| 138 | regulation of ARF GTPase activity (GO:0032312) | 2.29597553 |
| 139 | positive regulation of receptor recycling (GO:0001921) | 2.27233407 |
| 140 | regulation of beta-amyloid formation (GO:1902003) | 2.26889841 |
| 141 | regulation of female receptivity (GO:0045924) | 2.25244223 |
| 142 | neutrophil activation (GO:0042119) | 2.24043289 |
| 143 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.23800231 |
| 144 | central nervous system myelination (GO:0022010) | 2.23775902 |
| 145 | axon ensheathment in central nervous system (GO:0032291) | 2.23775902 |
| 146 | granulocyte activation (GO:0036230) | 2.23246837 |
| 147 | myelin maintenance (GO:0043217) | 2.22679908 |
| 148 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.21452316 |
| 149 | positive regulation of mast cell activation (GO:0033005) | 2.21138921 |
| 150 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.20872281 |
| 151 | protein targeting to plasma membrane (GO:0072661) | 2.20864405 |
| 152 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.19619808 |
| 153 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.19581676 |
| 154 | germinal center formation (GO:0002467) | 2.19238509 |
| 155 | detection of other organism (GO:0098543) | 2.19129014 |
| 156 | barbed-end actin filament capping (GO:0051016) | 2.18247786 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.70117188 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.03913292 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.01247247 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.89676207 |
| 5 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.73773013 |
| 6 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.67522907 |
| 7 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.60766923 |
| 8 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.54215144 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.52322513 |
| 10 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.52188527 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.49783430 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.45544096 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.45544096 |
| 14 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.45135398 |
| 15 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.45115303 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.44242456 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.39802749 |
| 18 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.39291748 |
| 19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.37959386 |
| 20 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.29501508 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.27026654 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.21949825 |
| 23 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.08515756 |
| 24 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.99940927 |
| 25 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.95596720 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.92467432 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.91840019 |
| 28 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.90357815 |
| 29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.90072072 |
| 30 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.83955631 |
| 31 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83891336 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.82488224 |
| 33 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.81851132 |
| 34 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.80555461 |
| 35 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.78064091 |
| 36 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.77994815 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.75746333 |
| 38 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.75542259 |
| 39 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.70772513 |
| 40 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.70620953 |
| 41 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.68602184 |
| 42 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.65318127 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.62948303 |
| 44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.61105738 |
| 45 | GATA1_19941826_ChIP-Seq_K562_Human | 1.59467723 |
| 46 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.58732969 |
| 47 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.56885315 |
| 48 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.56831712 |
| 49 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.54233149 |
| 50 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.52541879 |
| 51 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.50610444 |
| 52 | * P68_20966046_ChIP-Seq_HELA_Human | 1.50286282 |
| 53 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.47660300 |
| 54 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.47234834 |
| 55 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.46784400 |
| 56 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.44669946 |
| 57 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.42497344 |
| 58 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.40032076 |
| 59 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.35443115 |
| 60 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.35060629 |
| 61 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.35015025 |
| 62 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.33762205 |
| 63 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33609808 |
| 64 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32406213 |
| 65 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31362412 |
| 66 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.31037420 |
| 67 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.29524092 |
| 68 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.27161210 |
| 69 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26675051 |
| 70 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.26209704 |
| 71 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.26137259 |
| 72 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.24016871 |
| 73 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.23286901 |
| 74 | MAF_26560356_Chip-Seq_TH1_Human | 1.23233070 |
| 75 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.23211754 |
| 76 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.23172055 |
| 77 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.22666959 |
| 78 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.21108199 |
| 79 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.19784571 |
| 80 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.19739109 |
| 81 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.19628771 |
| 82 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.19323489 |
| 83 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.19112156 |
| 84 | * MYC_22102868_ChIP-Seq_BL_Human | 1.19050549 |
| 85 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.18418617 |
| 86 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18180610 |
| 87 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.17918767 |
| 88 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.17876790 |
| 89 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17831085 |
| 90 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.17344124 |
| 91 | UTX_26944678_Chip-Seq_JUKART_Human | 1.17132928 |
| 92 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.16342953 |
| 93 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.15976951 |
| 94 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.15169036 |
| 95 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.13741404 |
| 96 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12716562 |
| 97 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.11686452 |
| 98 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.11588333 |
| 99 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.10823682 |
| 100 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09273537 |
| 101 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.08780065 |
| 102 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07979282 |
| 103 | KDM2B_26808549_Chip-Seq_K562_Human | 1.07892474 |
| 104 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07341255 |
| 105 | SA1_27219007_Chip-Seq_Bcells_Human | 1.07303727 |
| 106 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06944695 |
| 107 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.06594081 |
| 108 | MAF_26560356_Chip-Seq_TH2_Human | 1.06503548 |
| 109 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.05374333 |
| 110 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05008226 |
| 111 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.04989911 |
| 112 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04414834 |
| 113 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.03798591 |
| 114 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.03486275 |
| 115 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.02518978 |
| 116 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02201835 |
| 117 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.01914946 |
| 118 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01594176 |
| 119 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.00948113 |
| 120 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.00305233 |
| 121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99767341 |
| 122 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98473620 |
| 123 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98285573 |
| 124 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.97193401 |
| 125 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96495642 |
| 126 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.96070723 |
| 127 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.95834719 |
| 128 | AR_25329375_ChIP-Seq_VCAP_Human | 0.95075696 |
| 129 | AR_19668381_ChIP-Seq_PC3_Human | 0.94093588 |
| 130 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93148832 |
| 131 | P300_19829295_ChIP-Seq_ESCs_Human | 0.91952904 |
| 132 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.91155170 |
| 133 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90539834 |
| 134 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.89384344 |
| 135 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88219223 |
| 136 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.87564958 |
| 137 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86801406 |
| 138 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.85755266 |
| 139 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.84953409 |
| 140 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.84617630 |
| 141 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.84486538 |
| 142 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84230000 |
| 143 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.83490818 |
| 144 | VDR_22108803_ChIP-Seq_LS180_Human | 0.82879063 |
| 145 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.82527420 |
| 146 | STAT3_23295773_ChIP-Seq_U87_Human | 0.82494059 |
| 147 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.82219836 |
| 148 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.80454695 |
| 149 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.78274732 |
| 150 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.78217762 |
| 151 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.77974043 |
| 152 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.77968754 |
| 153 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76602366 |
| 154 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.76521527 |
| 155 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.76130341 |
| 156 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.75985327 |
| 157 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.75629148 |
| 158 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.75223370 |
| 159 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.74996583 |
| 160 | TCF4_23295773_ChIP-Seq_U87_Human | 0.74485317 |
| 161 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.74161952 |
| 162 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.74080685 |
| 163 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.73240422 |
| 164 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.73022601 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.43272579 |
| 2 | MP0003880_abnormal_central_pattern | 4.25241318 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.69924454 |
| 4 | MP0004270_analgesia | 3.40677889 |
| 5 | MP0002064_seizures | 3.25335643 |
| 6 | MP0009046_muscle_twitch | 3.14207752 |
| 7 | MP0009745_abnormal_behavioral_response | 3.09947490 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.02668596 |
| 9 | MP0003303_peritoneal_inflammation | 3.00061183 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.86680373 |
| 11 | MP0002272_abnormal_nervous_system | 2.75441139 |
| 12 | MP0002736_abnormal_nociception_after | 2.64170376 |
| 13 | MP0003436_decreased_susceptibility_to | 2.62322448 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.53649953 |
| 15 | MP0002572_abnormal_emotion/affect_behav | 2.52072790 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.51040287 |
| 17 | MP0005464_abnormal_platelet_physiology | 2.50017616 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.47007581 |
| 19 | MP0003724_increased_susceptibility_to | 2.46124784 |
| 20 | MP0002822_catalepsy | 2.40287853 |
| 21 | MP0003329_amyloid_beta_deposits | 2.32937569 |
| 22 | MP0001486_abnormal_startle_reflex | 2.23394693 |
| 23 | MP0001501_abnormal_sleep_pattern | 2.18528204 |
| 24 | MP0002733_abnormal_thermal_nociception | 2.10195594 |
| 25 | MP0004858_abnormal_nervous_system | 2.08148475 |
| 26 | MP0001970_abnormal_pain_threshold | 2.05698438 |
| 27 | MP0008260_abnormal_autophagy | 2.02761295 |
| 28 | MP0008569_lethality_at_weaning | 2.01116891 |
| 29 | MP0002067_abnormal_sensory_capabilities | 1.94430172 |
| 30 | MP0001440_abnormal_grooming_behavior | 1.90418805 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.89351556 |
| 32 | MP0002909_abnormal_adrenal_gland | 1.87760094 |
| 33 | MP0005646_abnormal_pituitary_gland | 1.78452371 |
| 34 | MP0009780_abnormal_chondrocyte_physiolo | 1.78127571 |
| 35 | MP0009840_abnormal_foam_cell | 1.74496271 |
| 36 | MP0003879_abnormal_hair_cell | 1.71930233 |
| 37 | MP0004142_abnormal_muscle_tone | 1.64838859 |
| 38 | MP0001984_abnormal_olfaction | 1.58132642 |
| 39 | MP0002419_abnormal_innate_immunity | 1.58015200 |
| 40 | MP0006276_abnormal_autonomic_nervous | 1.57607266 |
| 41 | MP0006082_CNS_inflammation | 1.55132525 |
| 42 | MP0003633_abnormal_nervous_system | 1.54900839 |
| 43 | MP0005000_abnormal_immune_tolerance | 1.54757896 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.53218698 |
| 45 | MP0004811_abnormal_neuron_physiology | 1.52758422 |
| 46 | MP0005386_behavior/neurological_phenoty | 1.52596485 |
| 47 | MP0004924_abnormal_behavior | 1.52596485 |
| 48 | MP0004043_abnormal_pH_regulation | 1.51201806 |
| 49 | MP0001905_abnormal_dopamine_level | 1.51138749 |
| 50 | MP0000920_abnormal_myelination | 1.49953319 |
| 51 | MP0004885_abnormal_endolymph | 1.49321771 |
| 52 | MP0005025_abnormal_response_to | 1.48296155 |
| 53 | MP0002557_abnormal_social/conspecific_i | 1.47338214 |
| 54 | MP0002184_abnormal_innervation | 1.45107458 |
| 55 | MP0001502_abnormal_circadian_rhythm | 1.43122479 |
| 56 | MP0002066_abnormal_motor_capabilities/c | 1.39200268 |
| 57 | MP0000955_abnormal_spinal_cord | 1.38890495 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.37300200 |
| 59 | MP0003690_abnormal_glial_cell | 1.37238327 |
| 60 | MP0000013_abnormal_adipose_tissue | 1.37004538 |
| 61 | MP0001529_abnormal_vocalization | 1.34935162 |
| 62 | MP0001986_abnormal_taste_sensitivity | 1.33758635 |
| 63 | MP0002229_neurodegeneration | 1.33489794 |
| 64 | MP0009278_abnormal_bone_marrow | 1.32729984 |
| 65 | MP0002148_abnormal_hypersensitivity_rea | 1.32338158 |
| 66 | MP0002837_dystrophic_cardiac_calcinosis | 1.32316723 |
| 67 | MP0005166_decreased_susceptibility_to | 1.31582876 |
| 68 | MP0002882_abnormal_neuron_morphology | 1.31348394 |
| 69 | MP0000343_altered_response_to | 1.31157506 |
| 70 | MP0004947_skin_inflammation | 1.31090814 |
| 71 | MP0003631_nervous_system_phenotype | 1.29481536 |
| 72 | MP0005671_abnormal_response_to | 1.29399028 |
| 73 | MP0001790_abnormal_immune_system | 1.26828558 |
| 74 | MP0005387_immune_system_phenotype | 1.26828558 |
| 75 | MP0004130_abnormal_muscle_cell | 1.23957435 |
| 76 | MP0003634_abnormal_glial_cell | 1.23922930 |
| 77 | MP0008004_abnormal_stomach_pH | 1.21769069 |
| 78 | MP0000604_amyloidosis | 1.21395546 |
| 79 | MP0005645_abnormal_hypothalamus_physiol | 1.21014520 |
| 80 | MP0005551_abnormal_eye_electrophysiolog | 1.20607423 |
| 81 | MP0008872_abnormal_physiological_respon | 1.19243938 |
| 82 | MP0001835_abnormal_antigen_presentation | 1.17987628 |
| 83 | MP0003183_abnormal_peptide_metabolism | 1.17616305 |
| 84 | MP0009785_altered_susceptibility_to | 1.16609649 |
| 85 | MP0000778_abnormal_nervous_system | 1.14972229 |
| 86 | MP0002723_abnormal_immune_serum | 1.14041203 |
| 87 | MP0005451_abnormal_body_composition | 1.13231069 |
| 88 | MP0003075_altered_response_to | 1.12939451 |
| 89 | MP0005535_abnormal_body_temperature | 1.07989996 |
| 90 | MP0000685_abnormal_immune_system | 1.07309337 |
| 91 | MP0002420_abnormal_adaptive_immunity | 1.05463167 |
| 92 | MP0000751_myopathy | 1.04788588 |
| 93 | MP0001819_abnormal_immune_cell | 1.03956693 |
| 94 | MP0001800_abnormal_humoral_immune | 1.00260792 |
| 95 | MP0003122_maternal_imprinting | 1.00212894 |
| 96 | MP0002452_abnormal_antigen_presenting | 0.97553865 |
| 97 | MP0002090_abnormal_vision | 0.97159336 |
| 98 | MP0008874_decreased_physiological_sensi | 0.95380997 |
| 99 | MP0004742_abnormal_vestibular_system | 0.95163029 |
| 100 | MP0002653_abnormal_ependyma_morphology | 0.95150918 |
| 101 | MP0001851_eye_inflammation | 0.94607042 |
| 102 | MP0002998_abnormal_bone_remodeling | 0.94414293 |
| 103 | MP0003172_abnormal_lysosome_physiology | 0.93764465 |
| 104 | MP0002069_abnormal_eating/drinking_beha | 0.92642645 |
| 105 | MP0003632_abnormal_nervous_system | 0.91694042 |
| 106 | MP0003866_abnormal_defecation | 0.90855422 |
| 107 | MP0010386_abnormal_urinary_bladder | 0.87591736 |
| 108 | MP0010155_abnormal_intestine_physiology | 0.87198584 |
| 109 | MP0003045_fibrosis | 0.87136283 |
| 110 | MP0002876_abnormal_thyroid_physiology | 0.85693711 |
| 111 | MP0001348_abnormal_lacrimal_gland | 0.85343484 |
| 112 | MP0001963_abnormal_hearing_physiology | 0.84102725 |
| 113 | MP0004145_abnormal_muscle_electrophysio | 0.81281993 |
| 114 | MP0004085_abnormal_heartbeat | 0.81034391 |
| 115 | MP0001765_abnormal_ion_homeostasis | 0.80936503 |
| 116 | MP0005397_hematopoietic_system_phenotyp | 0.79969943 |
| 117 | MP0001545_abnormal_hematopoietic_system | 0.79969943 |
| 118 | MP0001845_abnormal_inflammatory_respons | 0.79626917 |
| 119 | MP0002152_abnormal_brain_morphology | 0.79341387 |
| 120 | MP0005058_abnormal_lysosome_morphology | 0.79226342 |
| 121 | MP0003787_abnormal_imprinting | 0.79135564 |
| 122 | MP0005409_darkened_coat_color | 0.78966569 |
| 123 | MP0005083_abnormal_biliary_tract | 0.78536042 |
| 124 | MP0000858_altered_metastatic_potential | 0.78118591 |
| 125 | MP0003656_abnormal_erythrocyte_physiolo | 0.75780543 |
| 126 | MP0003828_pulmonary_edema | 0.74434742 |
| 127 | MP0009764_decreased_sensitivity_to | 0.73829730 |
| 128 | MP0003195_calcinosis | 0.72834012 |
| 129 | MP0000465_gastrointestinal_hemorrhage | 0.72047666 |
| 130 | MP0000716_abnormal_immune_system | 0.71634538 |
| 131 | MP0002398_abnormal_bone_marrow | 0.71300694 |
| 132 | MP0002752_abnormal_somatic_nervous | 0.71282116 |
| 133 | MP0004147_increased_porphyrin_level | 0.70851758 |
| 134 | MP0001664_abnormal_digestion | 0.68908625 |
| 135 | MP0005165_increased_susceptibility_to | 0.68867677 |
| 136 | MP0008961_abnormal_basal_metabolism | 0.68075241 |
| 137 | MP0003705_abnormal_hypodermis_morpholog | 0.67319546 |
| 138 | MP0004036_abnormal_muscle_relaxation | 0.66331932 |
| 139 | MP0003638_abnormal_response/metabolism_ | 0.65146719 |
| 140 | MP0005167_abnormal_blood-brain_barrier | 0.63449915 |
| 141 | MP0000749_muscle_degeneration | 0.63125757 |
| 142 | MP0001485_abnormal_pinna_reflex | 0.62980439 |
| 143 | MP0000747_muscle_weakness | 0.60720747 |
| 144 | MP0005410_abnormal_fertilization | 0.60249714 |
| 145 | MP0004510_myositis | 0.59923514 |
| 146 | MP0005394_taste/olfaction_phenotype | 0.58736759 |
| 147 | MP0005499_abnormal_olfactory_system | 0.58736759 |
| 148 | MP0000639_abnormal_adrenal_gland | 0.58690356 |
| 149 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.58333193 |
| 150 | MP0005253_abnormal_eye_physiology | 0.57966717 |
| 151 | MP0004215_abnormal_myocardial_fiber | 0.57399093 |
| 152 | MP0003646_muscle_fatigue | 0.57366388 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.22262916 |
| 2 | Focal motor seizures (HP:0011153) | 5.88730936 |
| 3 | Focal seizures (HP:0007359) | 4.55247232 |
| 4 | Epileptic encephalopathy (HP:0200134) | 4.45878682 |
| 5 | Atonic seizures (HP:0010819) | 4.44797770 |
| 6 | Visual hallucinations (HP:0002367) | 4.44515044 |
| 7 | Supranuclear gaze palsy (HP:0000605) | 3.92771473 |
| 8 | Febrile seizures (HP:0002373) | 3.79658421 |
| 9 | Pheochromocytoma (HP:0002666) | 3.67699073 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 3.64024856 |
| 11 | Purpura (HP:0000979) | 3.55121019 |
| 12 | Action tremor (HP:0002345) | 3.44864707 |
| 13 | Absence seizures (HP:0002121) | 3.38920575 |
| 14 | Neurofibrillary tangles (HP:0002185) | 3.35078171 |
| 15 | Ankle clonus (HP:0011448) | 3.34605857 |
| 16 | Generalized tonic-clonic seizures (HP:0002069) | 3.33969376 |
| 17 | Prolonged bleeding time (HP:0003010) | 3.33643851 |
| 18 | Eczematoid dermatitis (HP:0000976) | 3.31919694 |
| 19 | Obstructive sleep apnea (HP:0002870) | 3.31669335 |
| 20 | Neuroendocrine neoplasm (HP:0100634) | 3.28661107 |
| 21 | Abnormal eating behavior (HP:0100738) | 3.27536480 |
| 22 | Dialeptic seizures (HP:0011146) | 3.21890803 |
| 23 | Abnormality of macrophages (HP:0004311) | 3.18015001 |
| 24 | Depression (HP:0000716) | 3.17197835 |
| 25 | Anxiety (HP:0000739) | 3.11951786 |
| 26 | Petechiae (HP:0000967) | 2.95530129 |
| 27 | Dysmetria (HP:0001310) | 2.94769715 |
| 28 | Cerebral inclusion bodies (HP:0100314) | 2.85377249 |
| 29 | Postural instability (HP:0002172) | 2.78684628 |
| 30 | Dysdiadochokinesis (HP:0002075) | 2.78095881 |
| 31 | Hyperventilation (HP:0002883) | 2.76708657 |
| 32 | Dysostosis multiplex (HP:0000943) | 2.76291524 |
| 33 | Scanning speech (HP:0002168) | 2.70712310 |
| 34 | Poor eye contact (HP:0000817) | 2.68525620 |
| 35 | Truncal ataxia (HP:0002078) | 2.61439437 |
| 36 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.61416826 |
| 37 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.61416826 |
| 38 | Abnormality of glycolipid metabolism (HP:0010969) | 2.61416826 |
| 39 | Papilledema (HP:0001085) | 2.60983238 |
| 40 | Myositis (HP:0100614) | 2.58606961 |
| 41 | Torticollis (HP:0000473) | 2.58202481 |
| 42 | Abnormal social behavior (HP:0012433) | 2.57185708 |
| 43 | Impaired social interactions (HP:0000735) | 2.57185708 |
| 44 | Abnormality of the lower motor neuron (HP:0002366) | 2.54251198 |
| 45 | Epistaxis (HP:0000421) | 2.54029317 |
| 46 | Polyphagia (HP:0002591) | 2.52152366 |
| 47 | Orchitis (HP:0100796) | 2.52138236 |
| 48 | Menorrhagia (HP:0000132) | 2.51263415 |
| 49 | Tetraplegia (HP:0002445) | 2.50272653 |
| 50 | Cholecystitis (HP:0001082) | 2.49937354 |
| 51 | Abnormal gallbladder physiology (HP:0012438) | 2.49937354 |
| 52 | Apathy (HP:0000741) | 2.49380426 |
| 53 | Focal dystonia (HP:0004373) | 2.48350772 |
| 54 | Spastic gait (HP:0002064) | 2.48306527 |
| 55 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.44875116 |
| 56 | Axonal loss (HP:0003447) | 2.44389323 |
| 57 | Recurrent abscess formation (HP:0002722) | 2.42588565 |
| 58 | Amyloidosis (HP:0011034) | 2.42334201 |
| 59 | Gaze-evoked nystagmus (HP:0000640) | 2.41351559 |
| 60 | Intention tremor (HP:0002080) | 2.41092134 |
| 61 | Failure to thrive in infancy (HP:0001531) | 2.39192165 |
| 62 | Systemic lupus erythematosus (HP:0002725) | 2.39188931 |
| 63 | Diminished motivation (HP:0000745) | 2.37886085 |
| 64 | Limb dystonia (HP:0002451) | 2.37756029 |
| 65 | Diplopia (HP:0000651) | 2.36351997 |
| 66 | Abnormality of binocular vision (HP:0011514) | 2.36351997 |
| 67 | Loss of speech (HP:0002371) | 2.36143033 |
| 68 | Slow saccadic eye movements (HP:0000514) | 2.33964082 |
| 69 | Recurrent bacterial skin infections (HP:0005406) | 2.33391460 |
| 70 | Progressive inability to walk (HP:0002505) | 2.32493790 |
| 71 | Gingival bleeding (HP:0000225) | 2.31641371 |
| 72 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.30881618 |
| 73 | Psychosis (HP:0000709) | 2.29513234 |
| 74 | Craniofacial dystonia (HP:0012179) | 2.29486390 |
| 75 | Increased circulating renin level (HP:0000848) | 2.29478920 |
| 76 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.28132879 |
| 77 | Ventricular fibrillation (HP:0001663) | 2.26812016 |
| 78 | Epileptiform EEG discharges (HP:0011182) | 2.26471251 |
| 79 | Spontaneous hematomas (HP:0007420) | 2.25201290 |
| 80 | Bradykinesia (HP:0002067) | 2.24831379 |
| 81 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.24626231 |
| 82 | Hemiparesis (HP:0001269) | 2.23323386 |
| 83 | Chronic obstructive pulmonary disease (HP:0006510) | 2.22839109 |
| 84 | Obstructive lung disease (HP:0006536) | 2.22839109 |
| 85 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.22132159 |
| 86 | Delusions (HP:0000746) | 2.21096116 |
| 87 | Broad-based gait (HP:0002136) | 2.19217613 |
| 88 | Abnormal platelet volume (HP:0011876) | 2.19147403 |
| 89 | Status epilepticus (HP:0002133) | 2.18649045 |
| 90 | Optic neuritis (HP:0100653) | 2.17780472 |
| 91 | Retrobulbar optic neuritis (HP:0100654) | 2.17780472 |
| 92 | EEG with generalized epileptiform discharges (HP:0011198) | 2.16308921 |
| 93 | Urinary urgency (HP:0000012) | 2.16290287 |
| 94 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.15839834 |
| 95 | Rigidity (HP:0002063) | 2.14764341 |
| 96 | Neuronal loss in central nervous system (HP:0002529) | 2.12870843 |
| 97 | Amblyopia (HP:0000646) | 2.12135240 |
| 98 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.09476537 |
| 99 | Hypsarrhythmia (HP:0002521) | 2.09365746 |
| 100 | Retinal dysplasia (HP:0007973) | 2.09058661 |
| 101 | Abnormality of the corticospinal tract (HP:0002492) | 2.08838302 |
| 102 | Dementia (HP:0000726) | 2.08255337 |
| 103 | Episodic fever (HP:0001954) | 2.06707702 |
| 104 | Dysmetric saccades (HP:0000641) | 2.06533850 |
| 105 | Agitation (HP:0000713) | 2.04726840 |
| 106 | Mutism (HP:0002300) | 2.04387141 |
| 107 | Increased IgE level (HP:0003212) | 2.02592272 |
| 108 | Abnormality of saccadic eye movements (HP:0000570) | 2.01907801 |
| 109 | Peripheral hypomyelination (HP:0007182) | 2.01182673 |
| 110 | Generalized myoclonic seizures (HP:0002123) | 2.00756885 |
| 111 | Cellulitis (HP:0100658) | 1.99368754 |
| 112 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.98914361 |
| 113 | Termporal pattern (HP:0011008) | 1.96926597 |
| 114 | Insidious onset (HP:0003587) | 1.96926597 |
| 115 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.95769973 |
| 116 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.95769973 |
| 117 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.95769973 |
| 118 | Lower limb muscle weakness (HP:0007340) | 1.94128657 |
| 119 | Hypercortisolism (HP:0001578) | 1.93855452 |
| 120 | Genetic anticipation (HP:0003743) | 1.93044153 |
| 121 | Increased cerebral lipofuscin (HP:0011813) | 1.91894631 |
| 122 | Mediastinal lymphadenopathy (HP:0100721) | 1.91838621 |
| 123 | Impaired smooth pursuit (HP:0007772) | 1.90226312 |
| 124 | Memory impairment (HP:0002354) | 1.90068049 |
| 125 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.89584677 |
| 126 | Gout (HP:0001997) | 1.89578747 |
| 127 | Stomatitis (HP:0010280) | 1.89481568 |
| 128 | Megalencephaly (HP:0001355) | 1.89143696 |
| 129 | Postural tremor (HP:0002174) | 1.89111408 |
| 130 | Resting tremor (HP:0002322) | 1.87403024 |
| 131 | Polycythemia (HP:0001901) | 1.87066448 |
| 132 | Clonus (HP:0002169) | 1.86857636 |
| 133 | Rapidly progressive (HP:0003678) | 1.86152233 |
| 134 | Lower limb amyotrophy (HP:0007210) | 1.86100323 |
| 135 | Mucopolysacchariduria (HP:0008155) | 1.85852255 |
| 136 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.85852255 |
| 137 | Central scotoma (HP:0000603) | 1.85220419 |
| 138 | Gait ataxia (HP:0002066) | 1.84601665 |
| 139 | Poor suck (HP:0002033) | 1.84350980 |
| 140 | Distal upper limb amyotrophy (HP:0007149) | 1.84348852 |
| 141 | Upper limb amyotrophy (HP:0009129) | 1.84348852 |
| 142 | Impaired vibratory sensation (HP:0002495) | 1.84096203 |
| 143 | Increased mean platelet volume (HP:0011877) | 1.83907809 |
| 144 | Hemiplegia (HP:0002301) | 1.83551099 |
| 145 | Decreased motor nerve conduction velocity (HP:0003431) | 1.83442700 |
| 146 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.81142394 |
| 147 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.81142394 |
| 148 | Growth hormone excess (HP:0000845) | 1.80967076 |
| 149 | Cerebral hypomyelination (HP:0006808) | 1.80060728 |
| 150 | Inability to walk (HP:0002540) | 1.79785453 |
| 151 | Vertigo (HP:0002321) | 1.79531022 |
| 152 | Nuclear cataract (HP:0100018) | 1.78557564 |
| 153 | Foot dorsiflexor weakness (HP:0009027) | 1.78509474 |
| 154 | Clumsiness (HP:0002312) | 1.78251597 |
| 155 | Hepatosplenomegaly (HP:0001433) | 1.77716608 |
| 156 | Bundle branch block (HP:0011710) | 1.77481141 |
| 157 | Annular pancreas (HP:0001734) | 1.75797107 |
| 158 | Onion bulb formation (HP:0003383) | 1.75567614 |
| 159 | Stereotypic behavior (HP:0000733) | 1.74701673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.56384288 |
| 2 | MAP3K9 | 3.33419956 |
| 3 | EPHA4 | 3.26958171 |
| 4 | DAPK2 | 2.80345619 |
| 5 | MAP3K12 | 2.79992099 |
| 6 | CASK | 2.47731728 |
| 7 | ERN1 | 2.37404813 |
| 8 | MAP3K4 | 2.36263978 |
| 9 | MINK1 | 2.35201757 |
| 10 | KSR2 | 2.24057869 |
| 11 | ARAF | 2.21241787 |
| 12 | MAP2K7 | 2.15270096 |
| 13 | CDK19 | 2.12042505 |
| 14 | PRKD3 | 2.09967980 |
| 15 | PAK6 | 2.07764170 |
| 16 | RIPK1 | 1.95921585 |
| 17 | PRPF4B | 1.93625389 |
| 18 | NTRK1 | 1.83727951 |
| 19 | OXSR1 | 1.83502600 |
| 20 | GRK5 | 1.77593421 |
| 21 | TRIB3 | 1.72453310 |
| 22 | MAP2K4 | 1.67479967 |
| 23 | DAPK1 | 1.65286263 |
| 24 | TAOK2 | 1.62800940 |
| 25 | UHMK1 | 1.59922970 |
| 26 | MARK1 | 1.52716778 |
| 27 | MAP2K3 | 1.50290680 |
| 28 | NTRK2 | 1.49605371 |
| 29 | SGK494 | 1.44265026 |
| 30 | SGK223 | 1.44265026 |
| 31 | CAMKK1 | 1.42986881 |
| 32 | CDK5 | 1.42407763 |
| 33 | WNK4 | 1.42324398 |
| 34 | TESK1 | 1.39503290 |
| 35 | RIPK4 | 1.36562915 |
| 36 | MAP3K2 | 1.31835903 |
| 37 | MAP4K1 | 1.30162204 |
| 38 | PINK1 | 1.29503667 |
| 39 | MAP3K3 | 1.24639564 |
| 40 | STK39 | 1.21582110 |
| 41 | SIK1 | 1.21413221 |
| 42 | GRK6 | 1.21161694 |
| 43 | CAMKK2 | 1.18221172 |
| 44 | TESK2 | 1.16243514 |
| 45 | PHKG1 | 1.14216398 |
| 46 | PHKG2 | 1.14216398 |
| 47 | LMTK2 | 1.13946192 |
| 48 | PRKCG | 1.13361249 |
| 49 | MAP3K13 | 1.12929772 |
| 50 | PLK2 | 1.12868852 |
| 51 | MAPK12 | 1.12742007 |
| 52 | ZAP70 | 1.12424643 |
| 53 | STK38 | 1.09588304 |
| 54 | BLK | 1.09059189 |
| 55 | ICK | 1.08560937 |
| 56 | BMX | 1.08297904 |
| 57 | PTK2B | 1.07404583 |
| 58 | PRKCH | 1.02930269 |
| 59 | MAP3K1 | 1.01263881 |
| 60 | FES | 1.00248487 |
| 61 | WNK3 | 0.99510793 |
| 62 | MAPKAPK5 | 0.98489433 |
| 63 | CAMK2B | 0.97652059 |
| 64 | CAMK2A | 0.97174091 |
| 65 | TNIK | 0.95252522 |
| 66 | SIK3 | 0.95188063 |
| 67 | IRAK3 | 0.94569597 |
| 68 | TYK2 | 0.93580435 |
| 69 | CSK | 0.93010780 |
| 70 | CDK14 | 0.92519465 |
| 71 | CDK18 | 0.92189238 |
| 72 | TBK1 | 0.91780284 |
| 73 | CAMK1 | 0.89509469 |
| 74 | CDK15 | 0.89263321 |
| 75 | PRKD2 | 0.88668344 |
| 76 | WNK1 | 0.87597471 |
| 77 | PDPK1 | 0.86047281 |
| 78 | SYK | 0.83984098 |
| 79 | IRAK4 | 0.83595187 |
| 80 | NEK1 | 0.83580135 |
| 81 | MAPK13 | 0.81397273 |
| 82 | JAK2 | 0.81029172 |
| 83 | CAMK2G | 0.79944000 |
| 84 | CDK11A | 0.78886009 |
| 85 | CAMK2D | 0.78350291 |
| 86 | DAPK3 | 0.77356735 |
| 87 | HCK | 0.76536789 |
| 88 | LIMK1 | 0.75566059 |
| 89 | TAOK1 | 0.75251837 |
| 90 | KSR1 | 0.74781681 |
| 91 | JAK1 | 0.73926893 |
| 92 | PDK1 | 0.72945947 |
| 93 | RET | 0.72748124 |
| 94 | TYRO3 | 0.72551914 |
| 95 | PAK3 | 0.72369631 |
| 96 | CCNB1 | 0.70630093 |
| 97 | MAPK15 | 0.69548503 |
| 98 | TNK2 | 0.68753393 |
| 99 | IRAK2 | 0.68217816 |
| 100 | FGFR4 | 0.67712636 |
| 101 | SGK2 | 0.67506467 |
| 102 | BRAF | 0.67299263 |
| 103 | SGK3 | 0.65808600 |
| 104 | PRKG2 | 0.65039861 |
| 105 | FYN | 0.63587666 |
| 106 | SMG1 | 0.61176444 |
| 107 | BMPR2 | 0.60814505 |
| 108 | HIPK2 | 0.59477269 |
| 109 | ALK | 0.58207323 |
| 110 | BTK | 0.57728480 |
| 111 | PRKCE | 0.56553754 |
| 112 | FER | 0.56525436 |
| 113 | MAP2K1 | 0.55271534 |
| 114 | MARK2 | 0.55253365 |
| 115 | EPHB1 | 0.53138717 |
| 116 | PDK4 | 0.52275267 |
| 117 | PDK3 | 0.52275267 |
| 118 | PRKD1 | 0.51893612 |
| 119 | AKT3 | 0.49162011 |
| 120 | RPS6KA2 | 0.49075822 |
| 121 | ROCK2 | 0.48853430 |
| 122 | DYRK1B | 0.48133354 |
| 123 | FGR | 0.48001080 |
| 124 | STK11 | 0.46819498 |
| 125 | SGK1 | 0.46435686 |
| 126 | PRKCZ | 0.45584952 |
| 127 | RAF1 | 0.45141529 |
| 128 | BCR | 0.44808397 |
| 129 | DYRK1A | 0.44001310 |
| 130 | MAP3K11 | 0.43201749 |
| 131 | MATK | 0.43146264 |
| 132 | CAMK4 | 0.41191677 |
| 133 | CDC42BPA | 0.40620819 |
| 134 | MYLK | 0.39845978 |
| 135 | SIK2 | 0.38335997 |
| 136 | MAP2K6 | 0.37262915 |
| 137 | RPS6KA3 | 0.37195092 |
| 138 | GRK7 | 0.36715245 |
| 139 | PKN1 | 0.35903361 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.13082791 |
| 2 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.95902511 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.91274452 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.55373915 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.48651555 |
| 6 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.29994893 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.29380954 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.29248188 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.14100096 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.13617137 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 1.97430999 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.96802342 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 1.90510100 |
| 14 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.85080977 |
| 15 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.81844475 |
| 16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.79672849 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 1.75598048 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.62141530 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.61598180 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.61210331 |
| 21 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.60343490 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.53074642 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.47018113 |
| 24 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.46128756 |
| 25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.45797941 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.42219521 |
| 27 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.36472412 |
| 28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.35835241 |
| 29 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.35294685 |
| 30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.34868756 |
| 31 | Cocaine addiction_Homo sapiens_hsa05030 | 1.33957664 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.30237184 |
| 33 | Long-term depression_Homo sapiens_hsa04730 | 1.29788281 |
| 34 | Renin secretion_Homo sapiens_hsa04924 | 1.28167264 |
| 35 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.23488560 |
| 36 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.23395126 |
| 37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.23350869 |
| 38 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.21800131 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.19479556 |
| 40 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.18784538 |
| 41 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.18117344 |
| 42 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.14678950 |
| 43 | Tuberculosis_Homo sapiens_hsa05152 | 1.14605756 |
| 44 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.13802436 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13696556 |
| 46 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.12389155 |
| 47 | Leishmaniasis_Homo sapiens_hsa05140 | 1.08945743 |
| 48 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.05293997 |
| 49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.04608750 |
| 50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.03421560 |
| 51 | Platelet activation_Homo sapiens_hsa04611 | 1.03045926 |
| 52 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.02276910 |
| 53 | Phototransduction_Homo sapiens_hsa04744 | 1.01217928 |
| 54 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.99767898 |
| 55 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.97556106 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.97285629 |
| 57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.97019837 |
| 58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.97005332 |
| 59 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.96126839 |
| 60 | Gap junction_Homo sapiens_hsa04540 | 0.94938045 |
| 61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.94010834 |
| 62 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.90725396 |
| 63 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.89819562 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.87094232 |
| 65 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.86559747 |
| 66 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.85553358 |
| 67 | Malaria_Homo sapiens_hsa05144 | 0.84380003 |
| 68 | Parkinsons disease_Homo sapiens_hsa05012 | 0.83861448 |
| 69 | Alzheimers disease_Homo sapiens_hsa05010 | 0.80408650 |
| 70 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79296364 |
| 71 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.78781656 |
| 72 | Salmonella infection_Homo sapiens_hsa05132 | 0.78186002 |
| 73 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77950121 |
| 74 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.72183386 |
| 75 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72061588 |
| 76 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.71586040 |
| 77 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.70832622 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70478997 |
| 79 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.70015268 |
| 80 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.69638615 |
| 81 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.69120858 |
| 82 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.68869177 |
| 83 | Pertussis_Homo sapiens_hsa05133 | 0.68827336 |
| 84 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.68370157 |
| 85 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.68001930 |
| 86 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.67657902 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.67030939 |
| 88 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66561469 |
| 89 | Bile secretion_Homo sapiens_hsa04976 | 0.65626662 |
| 90 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.65408459 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64499439 |
| 92 | Lysosome_Homo sapiens_hsa04142 | 0.63569993 |
| 93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63401445 |
| 94 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.63170284 |
| 95 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.60863104 |
| 96 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.60214259 |
| 97 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.59937547 |
| 98 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59912266 |
| 99 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.59631924 |
| 100 | Prion diseases_Homo sapiens_hsa05020 | 0.59383406 |
| 101 | Glioma_Homo sapiens_hsa05214 | 0.58890870 |
| 102 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58877423 |
| 103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58306011 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58063954 |
| 105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57122339 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.56927848 |
| 107 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.56927845 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56916175 |
| 109 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.56640902 |
| 110 | Hepatitis C_Homo sapiens_hsa05160 | 0.56490084 |
| 111 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.55937255 |
| 112 | Melanogenesis_Homo sapiens_hsa04916 | 0.53501164 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53364321 |
| 114 | Axon guidance_Homo sapiens_hsa04360 | 0.53226373 |
| 115 | Shigellosis_Homo sapiens_hsa05131 | 0.52543481 |
| 116 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52534208 |
| 117 | Phagosome_Homo sapiens_hsa04145 | 0.48589116 |
| 118 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46832824 |
| 119 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46706995 |
| 120 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45486172 |
| 121 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.44058515 |
| 122 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43553002 |
| 123 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.43418748 |
| 124 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.42902724 |
| 125 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42095352 |
| 126 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.41866664 |
| 127 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.38214699 |
| 128 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37572169 |
| 129 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37539966 |
| 130 | Circadian rhythm_Homo sapiens_hsa04710 | 0.37084099 |
| 131 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37060633 |
| 132 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36239021 |
| 133 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34868641 |
| 134 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.34290646 |
| 135 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34180591 |
| 136 | Huntingtons disease_Homo sapiens_hsa05016 | 0.33411805 |
| 137 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32523347 |
| 138 | Carbon metabolism_Homo sapiens_hsa01200 | 0.30444536 |
| 139 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.28613021 |
| 140 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.28243594 |

